Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|9|1590-1596

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.9, 2015-09, pp. : 1590-1596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta‐analysis: comment

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 1162-1164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta‐analysis: reply

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 1164-1165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 11-12, 2015-12 ,pp. : 1239-1249

John Wiley & Sons Inc

Access to resources Recommend Favorite

New strategies for effective treatment of vitamin K antagonist‐associated bleeding

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S180-S186

John Wiley & Sons Inc

Access to resources Recommend Favorite

For How Long Should the Treatment with Vitamin K Antagonists Be Maintained?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 89-90

Karger

Access to resources Recommend Favorite